Your browser doesn't support javascript.
loading
Loss of H3K27 trimethylation in a distinct group of de-differentiated chordoma of the skull base.
Makise, Naohiro; Shimoi, Tatsunori; Sunami, Kuniko; Aoyagi, Yasuko; Kobayashi, Hiroshi; Tanaka, Shota; Kawai, Akira; Yonemori, Kan; Ushiku, Tetsuo; Yoshida, Akihiko.
Affiliation
  • Makise N; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo.
  • Shimoi T; Department of Medical Oncology, National Cancer Center Hospital, Tokyo.
  • Sunami K; Rare Cancer Center, National Cancer Center Hospital, Tokyo.
  • Aoyagi Y; Department of Laboratory Medicine, National Cancer Center Hospital, Tokyo.
  • Kobayashi H; Department of Precision Cancer Medicine, Center for Innovative Cancer Treatment, Tokyo Medical and Dental University, Tokyo.
  • Tanaka S; Department of Orthopedic Surgery, Graduate School of Medicine, The University of Tokyo.
  • Kawai A; Department of Neurosurgery, Graduate School of Medicine, The University of Tokyo.
  • Yonemori K; Rare Cancer Center, National Cancer Center Hospital, Tokyo.
  • Ushiku T; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo.
  • Yoshida A; Department of Medical Oncology, National Cancer Center Hospital, Tokyo.
Histopathology ; 82(3): 420-430, 2023 Feb.
Article in En | MEDLINE | ID: mdl-36217885
ABSTRACT
De-differentiated chordoma is defined as a high-grade sarcoma lacking notochordal differentiation, which arises in association with conventional chordoma. The mechanism underlying de-differentiation remains unclear. We immunohistochemically investigated trimethylation at lysine 27 of histone 3 (H3K27me3) in nine de-differentiated chordomas. The tumours occurred at the skull base (n = 5) or the sacrum (n = 4) in four men and five women with a median age of 50 years. De-differentiation occurred de novo in four cases and at recurrence/metastasis in five cases. Five tumours retained H3K27me3, whereas four showed complete loss of H3K27me3 only in the de-differentiated component, while the conventional chordoma component retained H3K27me3. All the H3K27me3-negative tumours showed co-loss of dimethylation at H3K27 (H3K27me2), consistent with inactivation of polycomb repressive complex 2. Two genetically analysed H3K27me3-negative tumours harboured EED homozygous deletions. All four H3K27me3-negative de-differentiated chordomas affected the skull base of young or middle-aged women. Unlike dense proliferation of highly pleomorphic spindle or epithelioid cells in the H3K27me3-positive de-differentiated chordomas, all H3K27me3-negative tumours displayed swirling fascicles of relatively uniform spindle cells with alternating cellularity and perivascular accentuation, resembling malignant peripheral nerve sheath tumour (MPNST). Rhabdomyoblastic differentiation was present in one H3K27me3-negative tumour. We identified a novel group of de-differentiated chordomas in the skull base that lost H3K27me3/me2 only in the de-differentiated component, which was associated with EED homozygous deletion and MPNST-like histology. Our data suggest a distinct 'polycomb-type' de-differentiation pathway in chordoma, similar to a recently described de-differentiated chondrosarcoma with H3K27me3 loss.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Chordoma / Neurofibrosarcoma Limits: Female / Humans / Male / Middle aged Language: En Journal: Histopathology Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Chordoma / Neurofibrosarcoma Limits: Female / Humans / Male / Middle aged Language: En Journal: Histopathology Year: 2023 Document type: Article